Development of lifitegrast: a novel T-cell inhibitor for the treatment of dry eye disease
Charles P Semba,1 Thomas R Gadek2 1Vascular and Interventional Radiology, Stanford University School of Medicine, Stanford, CA, USA; 2Ophthalma Logic Consulting, Park City, UT, USA Abstract: Dry eye disease (DED) is a multifactorial disorder of the ocular surface characterized by symptoms of disco...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/d5b2ba6793c64d6094fdf2f58bec4511 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|